{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:04:57Z","timestamp":1790892297639,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011489","name":"Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham","doi-asserted-by":"publisher","award":["No number"],"award-info":[{"award-number":["No number"]}],"id":[{"id":"10.13039\/100011489","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the resources and use of facilities at the Birmingham Veterans Affairs medical center","award":["No number"],"award-info":[{"award-number":["No number"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1606-z","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T08:19:22Z","timestamp":1527841162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Gout and the risk of myocardial infarction in older adults: a study of Medicare recipients"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3485-0006","authenticated-orcid":false,"given":"Jasvinder A.","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Cleveland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"key":"1606_CR1","unstructured":"Centers for Disease Control and Prevention. Heart disease. \n                    http:\/\/www.cdc.gov\/heartdisease\/\n                    \n                  . Accessed 28 Feb 2018."},{"issue":"23","key":"1606_CR2","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa0908610","volume":"362","author":"RW Yeh","year":"2010","unstructured":"Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010;362(23):2155\u201365.","journal-title":"N Engl J Med"},{"key":"1606_CR3","unstructured":"Centers for Disease Control and Prevention. Heart attack. \n                    https:\/\/www.cdc.gov\/heartdisease\/heart_attack.htm\n                    \n                  . Accessed 28 Feb 2018."},{"issue":"4","key":"1606_CR4","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.mcna.2007.03.007","volume":"91","author":"VL Roger","year":"2007","unstructured":"Roger VL. Epidemiology of myocardial infarction. Med Clin North Am. 2007;91(4):537\u201352. ix","journal-title":"Med Clin North Am"},{"issue":"1","key":"1606_CR5","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ahj.2005.02.028","volume":"151","author":"TL Kauf","year":"2006","unstructured":"Kauf TL, Velazquez EJ, Crosslin DR, Weaver WD, Diaz R, Granger CB, McMurray JJ, Rouleau JL, Aylward PE, White HD, et al. The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry. Am Heart J. 2006;151(1):206\u201312.","journal-title":"Am Heart J"},{"issue":"3","key":"1606_CR6","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/S0008-6363(01)00388-1","volume":"53","author":"JE Roeters van Lennep","year":"2002","unstructured":"Roeters van Lennep JE, Westerveld HT, Erkelens DW, van der Wall EE. Risk factors for coronary heart disease: implications of gender. Cardiovasc Res. 2002;53(3):538\u201349.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"1606_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/art.22466","volume":"57","author":"HK Choi","year":"2007","unstructured":"Choi HK, Ford ES, Li C, Curhan G. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2007;57(1):109\u201315.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"1606_CR8","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","volume":"125","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Pandya BJ, Choi HK. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008. Am J Med. 2012;125(7):679\u201387. e671","journal-title":"Am J Med"},{"issue":"3","key":"1606_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0895-4356(88)90127-8","volume":"41","author":"RD Abbott","year":"1988","unstructured":"Abbott RD, Brand FN, Kannel WB, Castelli WP. Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol. 1988;41(3):237\u201342.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"1606_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/fampra\/cmg413","volume":"20","author":"HJ Janssens","year":"2003","unstructured":"Janssens HJ, van de Lisdonk EH, Bor H, van den Hoogen HJ, Janssen M. Gout, just a nasty event or a cardiovascular signal? A study from primary care. Fam Pract. 2003;20(4):413\u20136.","journal-title":"Fam Pract"},{"issue":"6","key":"1606_CR11","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1136\/ard.2009.122770","volume":"69","author":"MA De Vera","year":"2010","unstructured":"De Vera MA, Rahman MM, Bhole V, Kopec JA, Choi HK. Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study. Ann Rheum Dis. 2010;69(6):1162\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1606_CR12","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1002\/art.22014","volume":"54","author":"E Krishnan","year":"2006","unstructured":"Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum. 2006;54(8):2688\u201396.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"1606_CR13","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1093\/rheumatology\/ket293","volume":"52","author":"OO Seminog","year":"2013","unstructured":"Seminog OO, Goldacre MJ. Gout as a risk factor for myocardial infarction and stroke in England: evidence from record linkage studies. Rheumatology (Oxford). 2013;52(12):2251\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1606_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/rheumatology\/kes169","volume":"52","author":"CF Kuo","year":"2013","unstructured":"Kuo CF, Yu KH, See LC, Chou IJ, Ko YS, Chang HC, Chiou MJ, Luo SF. Risk of myocardial infarction among patients with gout: a nationwide population-based study. Rheumatology (Oxford). 2013;52(1):111\u20137.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"1606_CR15","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.jacc.2005.05.084","volume":"46","author":"KP Alexander","year":"2005","unstructured":"Alexander KP, Roe MT, Chen AY, Lytle BL, Pollack CV Jr, Foody JM, Boden WE, Smith SC Jr, Gibler WB, Ohman EM, et al. Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol. 2005;46(8):1479\u201387.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"1606_CR16","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1093\/oxfordjournals.eurheartj.a015468","volume":"18","author":"C Rask-Madsen","year":"1997","unstructured":"Rask-Madsen C, Jensen G, Kober L, Melchior T, Torp-Pedersen C, Hildebrand P. Age-related mortality, clinical heart failure, and ventricular fibrillation in 4259 Danish patients after acute myocardial infarction. Eur Heart J. 1997;18(9):1426\u201331.","journal-title":"Eur Heart J"},{"issue":"11","key":"1606_CR17","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1001\/jama.1992.03490110055029","volume":"268","author":"JH Gurwitz","year":"1992","unstructured":"Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA. 1992;268(11):1417\u201322.","journal-title":"JAMA"},{"key":"1606_CR18","unstructured":"US Census Bureau. National population projections. I. Summary files. Total population by age, sex, race and Hispanic origin. (NP-T4-F). Projections of the total redodent population by 5-year age groups, race and Hispanic origin with special age categories: middle series. 2025 to 2045. \n                    https:\/\/www2.census.gov\/programs-surveys\/popproj\/tables\/2000\/2000-national-summary-tables\/np-t4-f.pdf\n                    \n                  . Accessed 28 Feb 2018."},{"key":"1606_CR19","unstructured":"CMS fee information. \n                    https:\/\/www.resdac.org\/resconnect\/articles\/123\n                    \n                  . Accessed 28 Feb 2018."},{"issue":"5","key":"1606_CR20","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/art.22767","volume":"57","author":"JA Singh","year":"2007","unstructured":"Singh JA, Hodges JS, Toscano JP, Asch SM. Quality of care for gout in the US needs improvement. Arthritis Rheum. 2007;57(5):822\u20139.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1606_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ahj.2004.02.013","volume":"148","author":"Y Kiyota","year":"2004","unstructured":"Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH. Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J. 2004;148(1):99\u2013104.","journal-title":"Am Heart J"},{"issue":"1","key":"1606_CR22","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s13075-017-1427-5","volume":"19","author":"JA Singh","year":"2017","unstructured":"Singh JA, Ramachandaran R, Yu S, Yang S, Xie F, Yun H, Zhang J, Curtis JR. Is gout a risk equivalent to diabetes for stroke and myocardial infarction? A retrospective claims database study. Arthritis Res Ther. 2017;19(1):228.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"1606_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/01.mlr.0000160417.39497.a9","volume":"43","author":"E Birman-Deych","year":"2005","unstructured":"Birman-Deych E, Waterman AD, Yan Y, Nilasena DS, Radford MJ, Gage BF. Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. Med Care. 2005;43(5):480\u20135.","journal-title":"Med Care"},{"issue":"10","key":"1606_CR24","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/0895-4356(93)90103-8","volume":"46","author":"PS Romano","year":"1993","unstructured":"Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46(10):1075\u20139. discussion 1081-1090","journal-title":"J Clin Epidemiol"},{"issue":"13","key":"1606_CR25","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1001\/archinte.1997.00440340060005","volume":"157","author":"AC Gelber","year":"1997","unstructured":"Gelber AC, Klag MJ, Mead LA, Thomas J, Thomas DJ, Pearson TA, Hochberg MC. Gout and risk for subsequent coronary heart disease. The Meharry-Hopkins Study. Arch Intern Med. 1997;157(13):1436\u201340.","journal-title":"Arch Intern Med"},{"issue":"7081","key":"1606_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440(7081):237\u201341.","journal-title":"Nature"},{"issue":"Suppl 1","key":"1606_CR27","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/ar1908","volume":"8","author":"BN Cronstein","year":"2006","unstructured":"Cronstein BN, Terkeltaub R. The inflammatory process of gout and its treatment. Arthritis Res Ther. 2006;8(Suppl 1):S3.","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"1606_CR28","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/hc0902.104353","volume":"105","author":"P Libby","year":"2002","unstructured":"Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135\u201343.","journal-title":"Circulation"},{"issue":"2","key":"1606_CR29","first-page":"179","volume":"124","author":"P Libby","year":"1986","unstructured":"Libby P, Ordovas JM, Auger KR, Robbins AH, Birinyi LK, Dinarello CA. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am J Pathol. 1986;124(2):179\u201385.","journal-title":"Am J Pathol"},{"issue":"8","key":"1606_CR30","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nrd3800","volume":"11","author":"CA Dinarello","year":"2012","unstructured":"Dinarello CA, Simon A, van der Meer JW. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov. 2012;11(8):633\u201352.","journal-title":"Nat Rev Drug Discov"},{"issue":"6327","key":"1606_CR31","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1126\/science.aag1381","volume":"355","author":"JJ Fuster","year":"2017","unstructured":"Fuster JJ, MacLauchlan S, Zuriaga MA, Polackal MN, Ostriker AC, Chakraborty R, Wu CL, Sano S, Muralidharan S, Rius C, et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science. 2017;355(6327):842\u20137.","journal-title":"Science"},{"issue":"20","key":"1606_CR32","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1161\/CIRCULATIONAHA.115.016160","volume":"132","author":"HB Sager","year":"2015","unstructured":"Sager HB, Heidt T, Hulsmans M, Dutta P, Courties G, Sebas M, Wojtkiewicz GR, Tricot B, Iwamoto Y, Sun Y, et al. Targeting interleukin-1beta reduces leukocyte production after acute myocardial infarction. Circulation. 2015;132(20):1880\u201390.","journal-title":"Circulation"},{"issue":"2","key":"1606_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, McConkey M, Gupta N, Gabriel S, Ardissino D, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med. 2017;377(2):111\u201321.","journal-title":"N Engl J Med"},{"issue":"3","key":"1606_CR34","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1172\/JCI118476","volume":"97","author":"H Shimokawa","year":"1996","unstructured":"Shimokawa H, Ito A, Fukumoto Y, Kadokami T, Nakaike R, Sakata M, Takayanagi T, Egashira K, Takeshita A. Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor. J Clin Invest. 1996;97(3):769\u201376.","journal-title":"J Clin Invest"},{"issue":"4","key":"1606_CR35","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1161\/01.ATV.0000064374.15232.C3","volume":"23","author":"H Kirii","year":"2003","unstructured":"Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y, Asano M, Moriwaki H, Seishima M. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 2003;23(4):656\u201360.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9822","key":"1606_CR36","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/S0140-6736(11)61931-4","volume":"379","author":"N Sarwar","year":"2012","unstructured":"Collaboration IRGCERF, Sarwar N, Butterworth AS, Freitag DF, Gregson J, Willeit P, Gorman DN, Gao P, Saleheen D, Rendon A, et al. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet. 2012;379(9822):1205\u201313.","journal-title":"Lancet"},{"issue":"9822","key":"1606_CR37","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","volume":"379","author":"DI Swerdlow","year":"2012","unstructured":"Interleukin-6 Receptor Mendelian Randomisation Analysis Consortium, Swerdlow DI, Holmes MV, Kuchenbaecker KB, Engmann JE, Shah T, Sofat R, Guo Y, Chung C, Peasey A, et al. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet. 2012;379(9822):1214\u201324.","journal-title":"Lancet"},{"issue":"7293","key":"1606_CR38","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nunez G, Schnurr M, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010;464(7293):1357\u201361.","journal-title":"Nature"},{"issue":"9","key":"1606_CR39","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1161\/ATVBAHA.115.307312","volume":"36","author":"K Rajamaki","year":"2016","unstructured":"Rajamaki K, Mayranpaa MI, Risco A, Tuimala J, Nurmi K, Cuenda A, Eklund KK, Oorni K, Kovanen PT. p38delta MAPK: a novel regulator of NLRP3 inflammasome activation with increased expression in coronary atherogenesis. Arterioscler Thromb Vasc Biol. 2016;36(9):1937\u201346.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"1606_CR40","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1161\/CIRCULATIONAHA.113.002714","volume":"128","author":"H Xiao","year":"2013","unstructured":"Xiao H, Lu M, Lin TY, Chen Z, Chen G, Wang WC, Marin T, Shentu TP, Wen L, Gongol B, et al. Sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility. Circulation. 2013;128(6):632\u201342.","journal-title":"Circulation"},{"issue":"10","key":"1606_CR41","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1161\/CIRCRESAHA.115.304437","volume":"115","author":"EJ Folco","year":"2014","unstructured":"Folco EJ, Sukhova GK, Quillard T, Libby P. Moderate hypoxia potentiates interleukin-1beta production in activated human macrophages. Circ Res. 2014;115(10):875\u201383.","journal-title":"Circ Res"},{"issue":"9","key":"1606_CR42","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1161\/01.ATV.20.9.2094","volume":"20","author":"M Torzewski","year":"2000","unstructured":"Torzewski M, Rist C, Mortensen RF, Zwaka TP, Bienek M, Waltenberger J, Koenig W, Schmitz G, Hombach V, Torzewski J. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol. 2000;20(9):2094\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"18","key":"1606_CR43","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1161\/01.CIR.102.18.2165","volume":"102","author":"V Pasceri","year":"2000","unstructured":"Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102(18):2165\u20138.","journal-title":"Circulation"},{"issue":"21","key":"1606_CR44","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1161\/01.CIR.103.21.2531","volume":"103","author":"V Pasceri","year":"2001","unstructured":"Pasceri V, Cheng JS, Willerson JT, Yeh ET. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation. 2001;103(21):2531\u20134.","journal-title":"Circulation"},{"issue":"3","key":"1606_CR45","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/jama.287.3.337","volume":"287","author":"DW Kaufman","year":"2002","unstructured":"Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287(3):337\u201344.","journal-title":"JAMA"},{"issue":"1","key":"1606_CR46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/pds.3463","volume":"23","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Boudreau DM, Freedman AN. Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population. Pharmacoepidemiol Drug Saf. 2014;23(1):43\u201350.","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1606-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1606-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1606-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T01:01:48Z","timestamp":1559350908000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1606-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1606"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1606-z","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,1]]},"assertion":[{"value":"7 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The University of Alabama at Birmingham\u2019s Institutional Review Board approved this study and all investigations were conducted in conformity with ethical principles of research. The IRB waived the need for informed consent for this database study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"JAS has received research grants from Takeda and Savient and consultant fees from Savient, Takeda, Regeneron, Merz, Iroko, Bioiberica, Fidia, Crealta\/Horizon and Allergan pharmaceuticals, WebMD, UBM LLC, and National Institute of Health and the American College of Rheumatology. JAS serves as the principal investigator for an investigator-initiated study funded by Horizon pharmaceuticals through a grant to DINORA, Inc., a 501 (c)(3) entity. JAS is a member of the executive of OMERACT, an organization that develops outcome measures in rheumatology and receives arms-length funding from 36 companies; a member of the American College of Rheumatology\u2019s (ACR) Annual Meeting Planning Committee (AMPC); Chair of the ACR Meet-the-Professor, Workshop and Study Group Subcommittee; and a member of the Veterans Affairs Rheumatology Field Advisory Committee. JAS is the editor and Director of the UAB Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis. JDC has no relevant financial conflicts. There are no nonfinancial competing interests for either author.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"109"}}